A man's orgasms triggered flu-like symptoms and brain fog due to a rare condition called post-orgasmic illness syndrome .
Omalizumab has been shown to improve participants' responses to allergens The New England Journal of Medicine study could be a major breakthrough The FDA has approved the drug's use for the ...
Purpose: The pharmacology, efficacy, dosage, adverse events, and economics of omalizumab are discussed. Summary: Omalizumab, a recombinant DNA-derived humanized monoclonal antibody, binds to the ...
Robert Wood, the director of the Eudowood Division of Allergy, Immunology, and Rheumatology at Johns Hopkins Children’s ...
Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab. Methods ...
Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain adults and children one year or older for the reduction of ...
SAN CARLOS, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (Company) (Nasdaq: ALLK), today announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria ...
Shares of Allakos (ALLK) are down 75% in pre-market trading after the company announced it will discontinue further clinical development of ...